NASDAQ:AVIR | Profit Breakdown | Atea Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$35.1M-$32.91M-$32.93M
2026-03-31-$48.01M-$45.39M-$45.44M
2025-12-31-$54.93M-$51.64M-$44.87M
2025-09-30-$45.57M-$41.85M-$42.05M
2025-06-30-$41.35M-$36.95M-$37.16M
2025-03-31-$39.04M-$34.07M-$34.27M
2024-12-31-$39.03M-$33.32M-$33.54M
2024-09-30-$37.2M-$30.93M-$31.15M
2024-06-30-$46.92M-$40.28M-$40.52M
2024-03-31-$69.81M-$62.94M-$63.17M
2023-12-31-$46.57M-$38.82M-$39.16M
2023-09-30-$40.79M-$32.92M-$33.14M
2023-06-30-$35.24M-$27.93M-$28.18M
2023-03-31-$41.57M-$35.27M-$35.47M
2022-12-31-$39.9M-$34.31M-$34.43M
2022-09-30-$16.28M-$11.9M-$8.07M
2022-06-30-$32.3M-$31.22M-$31.34M
2022-03-31-$42.18M-$42.08M-$42.08M
2021-12-31$192.18M$121.18M$121.23M$117.13M
2021-09-30$32.81M-$22.15M-$22.09M-$28.19M
2021-06-30$60.39M$8.69M$8.74M$1.54M
2021-03-31$65.99M$30.66M$30.71M$30.71M
2020-12-31$20.65M$20.66M$20.66M
2020-09-30-$17.63M-$17.62M-$17.62M
2020-06-30-$10M-$9.99M-$9.99M
2020-03-31-$4.05M-$3.99M
2019-12-31-$4.75M-$4.66M
2019-09-30-$3.77M-$3.63M
2019-06-30-$3.55M
2019-03-31-$2.19M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$180.89M-$164.51M-$158.35M
2024-12-31-$192.95M-$167.46M-$168.39M
2023-12-31-$164.16M-$134.94M-$135.96M
2022-12-31-$130.65M-$119.5M-$115.91M
2021-12-31$351.37M$138.38M$138.59M$121.19M
2020-12-31$48.63M-$11.03M-$10.95M-$10.95M
2019-12-31-$14.61M-$14.03M-$14.03M
2018-12-31-$9.48M-$9.06M